DalsnaFinance Account

Colgate-Palmolive $CL

Consumer Staples · Household Products · NYSE/NASDAQ

S&P 500 Russell 1000 New York

Create a scorecard

$92.67

-0.11 (-0.12%)

As of Oct 15, 2026, 10:52 PM EDT

Price history

Loading chart…

Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Aug 3, 2026, the first target we tracked for CL.

Colgate-Palmolive (CL) is trading down at $92.67 (-0.12%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Consumer Staples sector.

Analyst price targets on CL

Current price targets from 3 firms average $94.3, median $90, ranging from $89 to $104 — the average is 2% above the current $92.7. Each is tracked to its date and scored the same way a member's call is.

RBC Capital Markets $88.4 → $104 by Sep 2027 Outperform Sep 8, 2026 via Investing.com · RBC Capital Markets's track record
Jefferies $89.9 → $89 by Aug 2027 Hold Aug 3, 2026 via Investing.com · Jefferies's track record
TD Cowen $89.9 → $90 by Aug 2027 Hold Aug 3, 2026 via Investing.com · TD Cowen's track record

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

Colgate-Palmolive revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)

Colgate-Palmolive annual financial statements
	FY2016Dec 2016	FY2017Dec 2017	FY2018Dec 2018	FY2019Dec 2019	FY2020Dec 2020	FY2021Dec 2021	FY2022Dec 2022	FY2023Dec 2023	FY2024Dec 2024	FY2025Dec 2025
Income statement
Revenue	$15.2B	$15.5B	$15.5B	$15.7B	$16.5B	$17.4B	$18.0B	$19.5B	$20.1B	$20.4B
Growth (year over year)	−5.2%	+1.7%	+0.6%	+1.0%	+5.0%	+5.8%	+3.1%	+8.3%	+3.3%	+1.4%
Gross profit	$9.12B	$9.28B	$9.23B	$9.32B	$10.0B	$10.4B	$10.2B	$11.3B	$12.2B	$12.3B
Gross margin	60.0%	60.0%	59.4%	59.4%	60.8%	59.6%	57.0%	58.2%	60.5%	60.1%
Operating income	$3.96B	$3.71B	$3.69B	$3.55B	$3.88B	$3.33B	$2.89B	$3.98B	$4.27B	$3.31B
Operating margin	26.0%	24.0%	23.8%	22.6%	23.6%	19.1%	16.1%	20.5%	21.2%	16.2%
Net income	$2.44B	$2.02B	$2.40B	$2.37B	$2.69B	$2.17B	$1.78B	$2.30B	$2.89B	$2.13B
Net margin	16.1%	13.1%	15.4%	15.1%	16.4%	12.4%	9.9%	11.8%	14.4%	10.5%
EPS (diluted)	$2.72	$2.28	$2.75	$2.75	$3.14	$2.55	$2.13	$2.77	$3.51	$2.63
Balance sheet
Cash and equivalents	$1.31B	$1.53B	$726.0M	$883.0M	$888.0M	$832.0M	$775.0M	$966.0M	$1.10B	$1.29B
Total assets	$12.1B	$12.7B	$12.2B	$15.0B	$15.9B	$15.0B	$15.7B	$16.4B	$16.0B	$16.3B
Total liabilities	$12.1B	$12.4B	$12.0B	$14.5B	$14.8B	$14.1B	$14.9B	$15.4B	$15.5B	$16.0B
Long-term debt	$6.52B	$6.57B	$6.35B	$7.33B	$7.33B	$7.19B	$8.74B	$8.22B	$7.29B	$6.87B
Shareholders' equity	−$243.0M	−$60.0M	−$102.0M	$117.0M	$743.0M	$609.0M	$401.0M	$609.0M	$212.0M	$54.0M
Cash flow
Operating cash flow	$3.14B	$3.05B	$3.06B	$3.13B	$3.72B	$3.33B	$2.56B	$3.75B	$4.11B	$4.20B
Capital expenditure	$593.0M	$553.0M	$436.0M	$335.0M	$409.0M	$567.0M	$696.0M	$705.0M	$561.0M	$564.0M
Free cash flow	$2.55B	$2.50B	$2.62B	$2.80B	$3.31B	$2.76B	$1.86B	$3.04B	$3.55B	$3.63B
Share buybacks	$1.33B	$1.40B	$1.24B	$1.20B	$1.48B	$1.32B	$1.31B	$1.13B	$1.74B	$1.21B

RevenueNet incomeNet margin (right axis, %)

Colgate-Palmolive quarterly financial statements
	Q3 FY24Sep 2024	Q4 FY24^†Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25^†Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Income statement
Revenue	$5.03B	$4.95B	$4.91B	$5.11B	$5.13B	$5.23B	$5.32B	$5.36B
Growth (year over year)	+2.4%	−0.1%	−3.0%	+1.0%	+1.9%	+5.8%	+8.4%	+4.9%
Gross profit	$3.07B	$2.98B	$2.99B	$3.07B	$3.05B	$3.15B	$3.23B	$3.30B
Gross margin	61.1%	60.3%	60.8%	60.1%	59.4%	60.2%	60.6%	61.5%
Operating income	$1.06B	$1.06B	$1.08B	$1.08B	$1.06B	$91.0M	$964.0M	$1.02B
Operating margin	21.2%	21.5%	21.9%	21.1%	20.6%	1.7%	18.1%	19.0%
Net income	$737.0M	$738.0M	$690.0M	$743.0M	$735.0M	−$36.0M	$646.0M	$693.0M
Net margin	14.6%	14.9%	14.1%	14.5%	14.3%	−0.7%	12.1%	12.9%
EPS (diluted)	$0.90	$0.89	$0.85	$0.91	$0.91	−$0.04	$0.80	$0.86
Balance sheet
Cash and equivalents	$1.23B	$1.10B	$1.11B	$1.22B	$1.28B	$1.29B	$1.33B	$1.37B
Total assets	$16.8B	$16.0B	$16.6B	$17.5B	$17.5B	$16.3B	$16.6B	$16.8B
Total liabilities	$15.9B	$15.5B	$15.9B	$16.4B	$16.3B	$16.0B	$16.1B	$16.2B
Long-term debt	$7.91B	$7.29B	$6.57B	$7.14B	$7.31B	$6.87B	$7.94B	$7.82B
Shareholders' equity	$435.0M	$212.0M	$363.0M	$702.0M	$856.0M	$54.0M	$145.0M	$236.0M
Cash flow
Operating cash flow	$1.17B	$1.27B	$600.0M	$884.0M	$1.26B	$1.45B	$747.0M	$995.0M
Capital expenditure	$134.0M	$184.0M	$124.0M	$108.0M	$155.0M	$177.0M	$138.0M	$128.0M
Free cash flow	$1.03B	$1.08B	$476.0M	$776.0M	$1.11B	$1.28B	$609.0M	$867.0M
Share buybacks	$295.0M	$455.0M	$284.0M	$232.0M	$288.0M	$406.0M	$306.0M	$291.0M

From Colgate-Palmolive's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Colgate-Palmolive

The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products.

Source: Wikipedia — Colgate-Palmolive